Latest Breaking News On - Accelerated approval to amgen - Page 1 : comparemela.com

Amgen and AstraZeneca reveal Phase 2a results for Tezspire in severe COPD, showing a 17% reduction in exacerbations, with notable improvements in lung function and quality of life for patients with higher blood eosinophil counts.

Astrazeneca plcAmgen incRespiratory questionnaireAccelerated approval to amgenDrug for small cell lung cancer